Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMD 188

Known as: BMD-188, BMD188 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A newly synthesized cyclic hydroxamic acid compound, BMD188 [cis-l-hydroxy-4-(l-naphthyl)-6-oc-tylpiperidine-2-one], was found to… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
1999
Highly Cited
1999
We recently developed a class of novel anti-prostate cancer compounds, cyclic hydroxamates that elicit a potent apoptotic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
BACKGROUND Prostate cancer is the most frequently diagnosed malignancy in the Western countries. Apoptosis-targeted drug… Expand
Is this relevant?
1999
1999
BACKGROUND In the preceding paper, we demonstrated that, BMD188 [cis-1-hydroxy-4-(1-naphthyl)-6-octylpiperidine-2-one], a newly… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Cytochrome c release from mitochondria to and subsequent accumulation in the cytosol has been considered a prerequisite for… Expand
Is this relevant?